UK markets close in 5 hours 14 minutes

Aerie Pharmaceuticals, Inc. (AERI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
12.10+0.16 (+1.34%)
At close: 4:00PM EDT

12.60 +0.50 (4.13%)
Before hours: 5:35AM EDT

Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Cash flows from operating activities
Net income
-200,759
-199,581
-232,569
-145,105
-99,059
Depreciation & amortisation
23,621
18,114
2,442
1,410
970
Stock-based compensation
43,002
45,093
38,728
26,078
16,794
Change in working capital
-19,524
-23,956
13,388
-1,314
627
Accounts receivable
-28,183
-35,639
-2,715
-
-
Inventory
-9,242
-10,257
-9,689
-
-
Accounts payable
-
-
26,583
925
2,479
Other working capital
-149,872
-160,388
-183,889
-109,183
-84,917
Other non-cash items
10,047
9,900
25,636
25,108
303
Net cash provided by operating activities
-143,613
-150,430
-152,576
-93,213
-79,840
Cash flows from investing activities
Investments in property, plant and equipment
-6,259
-9,958
-31,313
-15,970
-5,077
Acquisitions, net
-
-
0
-10,500
-
Purchases of investments
-181,288
-165,454
-56,195
-104,490
-35,169
Sales/maturities of investments
50,557
0
108,297
88,153
58,346
Other investing activities
-
-7,835
-
-
-
Net cash used for investing activities
-144,825
-183,247
20,789
-42,807
18,100
Cash flows from financing activities
Common stock issued
-
0
135,972
134,215
168,479
Other financing activities
-
-34,995
-2,566
-
-1,249
Net cash used provided by (used for) financing activities
273,749
274,799
137,036
135,644
168,625
Net change in cash
-14,689
-58,878
5,249
-376
106,885
Cash at beginning of period
148,868
202,818
197,569
197,945
91,060
Cash at end of period
134,179
143,940
202,818
197,569
197,945
Free cash flow
Operating cash flow
-143,613
-150,430
-152,576
-93,213
-79,840
Capital expenditure
-6,259
-9,958
-31,313
-15,970
-5,077
Free cash flow
-149,872
-160,388
-183,889
-109,183
-84,917
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more